<--- Back to Details
First PageDocument Content
Multiple sclerosis / Medicine / Cytokines / Autoimmune diseases / Monoclonal antibodies / Interferon beta-1a / Therapies under investigation for multiple sclerosis / Glatiramer acetate / Biogen Idec / Immunology / Immune system / Immunosuppressants
Date: 2014-02-11 22:59:56
Multiple sclerosis
Medicine
Cytokines
Autoimmune diseases
Monoclonal antibodies
Interferon beta-1a
Therapies under investigation for multiple sclerosis
Glatiramer acetate
Biogen Idec
Immunology
Immune system
Immunosuppressants

Microsoft Word - CT LIst 2011

Add to Reading List

Source URL: www.nationalmssociety.org

Download Document from Source Website

File Size: 432,89 KB

Share Document on Facebook

Similar Documents

Trustee Lynn Schenk Lynn Schenk is an attorney and consultant in private practice with extensive public policy and business experience. She serves on the Board of Directors for Sempra Energy, Biogen Idec, the Scripps Re

DocID: 1tNv2 - View Document

Tufts CSDD 2015 Leadership for Drug Development Teams Sponsor Rate Eligibility List: Amgen Inc. Bayer Healthcare Pharmaceuticals Biogen Idec, Inc. Biotechnology (BIO)

DocID: 1eCyL - View Document

Special Article Reprint • July 14, 2014 A CenterWatch Publication Biogen Idec turns to MyHealthTeam in successful test of social networks for enrolling MS clinical trial

DocID: 1d2zh - View Document

Tufts CSDD 2015 Postgraduate Course in Clinical Pharmacology, Drug Development, and Regulation Sponsor Rate Eligibility List: Amgen Inc. Bayer Healthcare Pharmaceuticals Biogen Idec, Inc. Biotechnology (BIO)

DocID: 1cLP6 - View Document

Astellas Pharma / Actelion / Technology / Pharmaceutics / Biogen Idec / Boehringer Ingelheim / Pharmaceutical industry

Bedrijf Abbvie Actelion Alcon ALK Abello Allergan

DocID: 1aFBs - View Document